RAD receives IND approval from US FDA for Betabart (RV-01)

by admin July 28, 2025

July 28, 2025

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

0

Facebook Twitter Google +Pinterest

A$20 Million Placement to Strategic Partner

Leadership Streamlining and Cost Reductions

Cygnus Metals Limited: Issue of Performance Rights

Kobo Resources Intersects 21.5 m at 1.14 g/t...

Canadian Investment Regulatory Organization Trade Resumption – STUD

Walker Lane Resources Ltd. Receives Positive Results from...

Top 5 Junior Gold Mining Stocks on the...

Crypto Market Recap: Strategy Eyes US$1 Billion Capital...

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Latest

Blackstone Completes Share Purchase Plan
Comet share sale and debt repayment
Agreement to Develop New Expandable Graphite Facility
RAD receives IND approval from US FDA for Betabart (RV-01)
Maiden Drill Program Commences at Oasis Uranium Project

Categories

Business (70)
Investing (516)
Politics (698)
World (262)

About us
Contacts
Privacy Policy
Terms & Conditions
Email Whitelisting

Disclaimer: toppricemarket.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Back To Top

RAD receives IND approval from US FDA for Betabart (RV-01)

Maiden Drill Program Commences at Oasis Uranium Project

Agreement to Develop New Expandable Graphite Facility

You may also like